IP Verse

Cell Culture Medium Comprising Small Peptides - EP3165600

The patent EP3165600 was granted to Life on Nov 2, 2022. The application was originally filed on Apr 22, 2011 under application number EP16192190A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3165600

LIFE
Application Number
EP16192190A
Filing Date
Apr 22, 2011
Status
Granted And Under Opposition
Sep 30, 2022
Grant Date
Nov 2, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MURGITROYDAug 2, 2023MURGITROYDADMISSIBLE
STRAWMANAug 2, 2023VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBADMISSIBLE
BOEHRINGER INGELHEIMAug 1, 2023OETKEADMISSIBLE
WALLINGER RICKER SCHLOTTER TOSTMANNAug 1, 2023RICKERADMISSIBLE

Patent Citations (30) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2005287666
DESCRIPTIONUS2007254358
DESCRIPTIONUS5534538
DESCRIPTIONWO9808934
EXAMINATIONEP0087750
EXAMINATIONEP0087751
EXAMINATIONEP2351833
OPPOSITIONEP0087750
OPPOSITIONEP0087751
OPPOSITIONEP0220379
OPPOSITIONEP2154244
OPPOSITIONEP2351833
OPPOSITIONGB2251249
OPPOSITIONUS4968696
OPPOSITIONUS5206220
OPPOSITIONUS5328844
OPPOSITIONUS5534538
OPPOSITIONWO0202591
OPPOSITIONWO2006026445
OPPOSITIONWO2008035631
OPPOSITIONWO2008141207
OPPOSITIONWO2010050448
OPPOSITIONWO8700195
OPPOSITIONWO8803150
SEARCHEP2610338
SEARCHWO03046141
SEARCHWO2008035631
SEARCHWO2008141207
SEARCHWO2012017925
SEARCHWO2012019160

Non-Patent Literature (NPL) Citations (63) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BATTISTA, P. J. ET AL., AM. BIOTECH LAB., (1994), vol. 12, pages 64 - 68-
DESCRIPTION- BROWN ET AL., J. CHROM., (1994), vol. A, 661, pages 279 - 285-
DESCRIPTION- Cell Culture Technology for Pharmaceutical and Cell-Based Therapies, TAYLOR AND FRANCIS GROUP, (2006), page 51-
DESCRIPTION- Cell Culture Technology for Pharmaceutical and Cell-Based Therapies, TAYLOR AND FRANCIS GROUP, (2006), page 52-
DESCRIPTION- Cell Culture Technology for Pharmaceutical and Cell-Based Therapies, TAYLOR AND FRANCIS GROUP, (2006), pages 15 - 40-
DESCRIPTION- Cell Culture Technology for Pharmaceutical and Cell-Based Therapies, TAYLOR AND FRANCIS GROUP, (2006), pages 156 - 174-
DESCRIPTION- Cell Culture Technology for Pharmaceutical and Cell-Based Therapies, TAYLOR AND FRANCIS GROUP, (2006), pages 349 - 386-
DESCRIPTION- Cell Culture Technology for Pharmaceutical and Cell-Based Therapies, TAYLOR AND FRANCIS GROUP, (2006), pages 42 - 50-
DESCRIPTION- EAGLE ET AL., SCIENCE, (1959), vol. 130, pages 432 - 37-
DESCRIPTION- JUN QU; YIMING WANG; GUAN LUO; ZHUPING WU; CHENGDUI YANG, ANAL. CHEM., (2002), vol. 74, pages 2034 - 2040-
DESCRIPTION- KAO, F.-T.; PUCK, T. T., PROC. NATL. ACAD. SCI. USA, (1968), vol. 60, pages 1275 - 1281-
DESCRIPTION- RINGER, S., "physiological solutions", J. PHYSIOL., (1980), vol. 3, pages 380 - 393-
DESCRIPTION- ROTH ET AL., IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY, (1988), vol. 24, no. 7, pages 696 - 98-
DESCRIPTION- VAN WANDELEN ET AL., J. CHROM., (1997), vol. A, 763, pages 11 - 22-
DESCRIPTION- WAYMOUTH, C., Cells and Tissues in Culture, ACADEMIC PRESS, (1965), vol. 1, pages 99 - 142-
DESCRIPTION- WAYMOUTH, C., IN VITRO, (1970), vol. 6, pages 109 - 127-
OPPOSITION- A Burgener, M Butler, "3 Medium Development", A Burgener, M Butler, Sadettin S. Ozturk , Wei-Shou Hu, Cell Culture Technology for Pharmaceutical and Cell-Based Therapies, Taylor & Francis, (20060101), pages 41 - 79, ISBN 978-0-8247-5334-4, XP055454641-
OPPOSITION- Anonymous, "2782, 2783, 4479, 8457, 9835, 9841 ", Anonymous, Maryadele J O'Neil, The Merck Index - An encyclopedia of chemicals, drugs, and biolologicals, New Jersey, USA, Merck Research Laboratories, (20060101), pages 1 - 7, XP093098552-
OPPOSITION- Anonymous, "2782, 2783, 8457, 9835, 9841", Anonymous, Maryadele J. O'Neil, The Merck Index - An encyclopedia of chemicals, drugs, and biolologicals, New Jersey, USA, Merck Research Laboratories, (20060101), pages 1 - 7, XP093098410-
OPPOSITION- Anonymous, "2782, 2783, 9835, 9841 ", Anonymous, O'neil Maryadele J, The Merck Index - An encyclopedia of chemicals, drugs, and biolologicals, Merck Research Laboratories, (20060101), pages 1 - 8, XP093098550-
OPPOSITION- Anonymous, "Advanced RPMI 1640 and D-MEM/F-12 Product News ", Gobco, (20040101), pages 1 - 4, Gobco, URL: https://assets.fishersci.com/TFS-Assets/LSG/brochures/B-12649-r1_EU_0704_Advance_Media_Product_News.pdf, (20230804), XP093070715-
OPPOSITION- Anonymous, "parenteral nutrition: information for patients", NHS, (20130717), pages 1 - 2, XP093098291-
OPPOSITION- Anonymous, "Product Information L-Tyrosine T 3754", (20060101), pages 1 - 1, Sigma Aldrich, (20170922), XP055409121-
OPPOSITION- Anonymous, "Product Information L-Tyrosine T 3754", (20060101), Sigma Aldrich, (20170922), XP055409121-
OPPOSITION- Bareuther Carol M, "Nutrition Options — Enteral and Parenteral Feedingss", (20080101), pages 1 - 4, Todaysgeriatricmedicine, URL: https://www.todaysgeriatricmedicine.com/archive/071708pf.shtml, (20231106), XP093098165-
OPPOSITION- Fresenius Kabi, "Dipeptiven concentrate for solution for infusion", Product leaflet, (20071001), Product leaflet, URL: https://www.old.health.gov.il/units/pharmacy/trufot/alonim/3701.pdf, (20170912), XP055405760-
OPPOSITION- Fürst Peter, "New Developments in Glutamine Delivery", The Journal of Nutrition, American Society for Nutrition, US, US , (20010901), vol. 131, no. 9, ISSN 0022-3166, pages 2562S - 2568S, XP008119215-
OPPOSITION- Fürst Peter, "Synthetic Dipeptides - A New Dimension in Clinical Nutrition The Parenteral and Enteral Nutrition Society of Asia : PENSA", The Parenteral and Enteral Nutrition Society of Asia : PENSA, (20001201), pages 1 - 2, The Parenteral and Enteral Nutrition Society of Asia : PENSA, URL: https%3A%2F%2Fwww.pensa-online.org%2Fnewsletter_detail.php%3Fid%3D26%26page%3D, (20230804), XP093070717-
OPPOSITION- J A Vazquez, H Daniel, S A Adibi, "Dipeptides in Parenteral Nutrition: From Basic Science to Clinical Applications", Nutr Clin Pract, (19930101), vol. 8, no. 3, doi:10.1177/011542659300800395, pages 95 - 105, XP055410612-
OPPOSITION- Jorge A. Vazquez, Et Al., "Dipeptides in Parenteral Nutrition: From Basic Science to Clinical Applications", Nutr Clin Pract, (19930101), pages 95 - 105, Nutr Clin Pract, (20170927), XP055410612-
OPPOSITION- Kati Erdmann, Nina Grosser, Katrin Schipporeit, Henning Schrãder, "The ACE inhibitory dipeptide Met-Tyr diminishes free radical formation in human endothelial cells via induction of heme oxygenase-1 and ferritin.", The Journal of nutrition, (20060801), vol. 136, no. 8, doi:10.1093/jn/136.8.2148, ISSN 0022-3166, pages 2148 - 2152, XP055063710-
OPPOSITION- Liangzhi Xie, Weichang Zhou, "Fed-Batch Cultivation of Mammalian Cells for the Production of Recombinant Proteins", Cell Culture Technology For Pharmaceutical And Cell -Based Therapies, CRC Press , (20051010), pages 349 - 386, XP055519908-
OPPOSITION- Peter Furst, "New Developments in Glutamine Delivery", The Journal of Nutrition, US , (20010901), vol. 131, no. 9, ISSN 0022-3166, pages 2562S - 2568S, XP008119215-
OPPOSITION- Peter Furst, "New Developments in Glutamine Delivery", The Journal of Nutrition, US , (20010901), vol. 131, no. 9 Suppl, doi:10.1093/jn/131.9.2562S, ISSN 0022-3166, pages 2562S - 2568S, XP008119215-
OPPOSITION- Peter Furst, "Synthetic Dipeptides - A New Dimension in Clinical Nutrition", PENSA-Newsletter, (20000901), vol. 1, no. 3, pages 1 - 2, XP055409123-
OPPOSITION- S.A Casnocha , R.A Wolfe, "Media , Animal Cell Culture", S.A Casnocha , R.A Wolfe, Flickinger Michael C; Drew Stephen W, Encyclopedia of Bioprocess Technology : Fermentation , Biocatalysis and Bioseparation, John Wiley & Sons Inc, (19990101), vol. 1-5, pages 1660 - 1676, XP055943853-
OPPOSITION- Vazquez Jorge A., Daniel Hannelore, Adibi Siamak A., "Dipeptides in Parenteral Nutrition: From Basic Science to Clinical Applications", Nutrition in Clinical Practice, (19930601), vol. 8, no. 3, doi:10.1177/011542659300800395, ISSN 0884-5336, pages 95 - 105, XP055410612-
OPPOSITION- Wilfred Druml, Et Al., "Utilization of Tyrosine-Containing Dipeptides and N-Acetyl-Tyrosine in Hepatic Failure", Hepatology, (19950101), vol. 21, no. 4, pages 923 - 928, XP055410617-
OPPOSITION- Wilfred Druml , Wolfgang Hubl , Erich Roth, Herbert Lochs, "Utilization of Tyrosine-Containing Dipeptides and N-Acetyl-Tyrosine in Hepatic Failure", Hepatology, (19950401), vol. 21, no. 4, pages 923 - 928, XP055410617-
OPPOSITION- Yasufumi Imamoto, Hisaya Tanaka, Ken Takahashi, Yoshinobu Konno and Toshiyuki Suzawa, "Advantage of Alagln as and Additive to Cell Culture Medium", Animal Cell Technology: Basic & Applied Aspects, (20100101), vol. 16, pages 65 - 71, ISBN 978-90-481-3892-0, XP001526136-
OPPOSITION- Yasufumi Imamoto, Hisaya Tanaka, Ken Takahashi, Yoshinobu Konno and Toshiyuki Suzawa, "Advantage of Alagln as and Additive to Cell Culture Medium", Yasufumi Imamoto, Hisaya Tanaka, Ken Takahashi, Yoshinobu Konno and Toshiyuki Suzawa, Masamichi Kamihira, Yoshinori Katakura, Akira Ito, Animal Cell Technology: Basic & Applied Aspects, Springer Dordrecht, (20100101), vol. 16, pages 65 - 71, doi:10.1007/978-90-481-3892-0, ISBN 978-90-481-3892-0, XP001526136-
OPPOSITION- Yasufumi Imamoto, Hisaya Tanaka, Ken Takahashi, Yoshinobu Konno and Toshiyuki Suzawa, "Advantage of Alagln as and Additive to Cell Culture Medium", Yasufumi Imamoto, Hisaya Tanaka, Ken Takahashi, Yoshinobu Konno and Toshiyuki Suzawa, Masamichi Kamihira, Yoshinori Katakura, Akira Ito, Animal Cell Technology: Basic & Applied Aspects, Springer Dordrecht, (20100101), vol. 16, pages 65 - 71, ISBN 978-90-481-3892-0, XP001526136-
OPPOSITION- Natarajan Vijayasankaran, Jincai Li, Robert Shawley, Aaron Chen, Masaru Shiratori, Martin Gawlitzek, Feng Li, Robert Kiss, Ashraf Amanullah, "Animal Cell Culture Media", Natarajan Vijayasankaran, Jincai Li, Robert Shawley, Aaron Chen, Masaru Shiratori, Martin Gawlitzek, Feng Li, Robert Kiss, Ashraf Amanullah, Flickinger, Michael C., Encyclopedia of Industrial Biotechnology: Bioprocess, Bioseparation, and Cell Technology., Hoboken, NJ , John Wiley & Sons , pages 1 - 15, doi:10.1002/9780470054581.eib030 , ISBN 978-0-471-79930-6, XP002708444
OPPOSITION- Jun-Ichiro Hata, Et Al, "Chemically defined medium for the production of biologically active substances of CHO cells", Cytotechnology, Springer Netherlands, Dordrecht, Dordrecht, (19920101), vol. 10, no. 1, doi:10.1007/BF00376095, ISSN 0920-9069, pages 9 - 14, XP055405745
OPPOSITION- Yoshiki Minamoto, Koji Ogawa, Hideki Abe, Yoko lochi and Koji Mitsugi, "Development of a serum-free and heat-sterilizable medium and continuous high-density cell culture", Cytotechnology, Dordrecht, (19910101), vol. 2, doi:10.1007/BF00573879, ISSN 0920-9069, pages S35 - S51, XP000996331
OPPOSITION- L Pollack, Et Al., "Cystinhaltige kurzkettige Peptide als potentielle Cystinquelle in der parenteralen Ernahrung", Z. Ernährungswiss, (19890101), vol. 28, doi:10.1007/BF02023689, pages 191 - 200, XP055409157
OPPOSITION- L Pollack , P Stehle , S Alberts , P Furst, "Cystinhaltige kurzkettige Peptide als potentielle Cystinquelle in der parenteralen Ernahrung", Zeitschrif fur Ernährungswissenschaft, (19890101), vol. 28, doi:10.1007/BF02023689, pages 191 - 200, XP055409157
OPPOSITION- E Roth , G Ollenschlager, G Hamilton, A Simmel, K Langer, W Fekl, R Jakesz, "Influence of Two Glutamine-Containing Dipeptides on Growth of Mammalian Cells ", In Vitro Cellular & Developmental Biology, (19980101), vol. 24, no. 7, doi:10.1007/BF02623607, pages 696 - 698, XP055410641
OPPOSITION- G Roth, Et Al., "Influence of Two Glutamine-Containing Dipeptides on Growth of Mammalian Cells ", In Vitro Cellular & Developmental Biology, (19980101), vol. 24, no. 7, doi:10.1007/BF02623607, pages 696 - 698, XP055410641
OPPOSITION- Ito, T. ; Moore, G.E., "The growth-stimulating activity of peptides on human hematopoietic cell cultures", Experimental Cell Research, AMSTERDAM, NL , (19690701), vol. 56, no. 1, doi:10.1016/0014-4827(69)90385-1, ISSN 0014-4827, pages 10 - 14, XP024854399
OPPOSITION- T. Ito , G.E. Moore, "The growth-stimulating activity of peptides on human hematopoietic cell cultures XP001014424", Experimental Cell Research, AMSTERDAM, NL , (19690101), vol. 56, no. 1, doi:10.1016/0014-4827(69)90385-1, ISSN 0014-4827, pages 10 - 14
OPPOSITION- Christie, A , Butler, M., "Glutamine-based dipeptides are utilized in mammalian cell culture by extracellular hydrolysis catalyzed by a specific peptidase", Journal of Biotechnology, Amsterdam NL , (19941115), vol. 37, no. 3, doi:10.1016/0168-1656(94)90134-1, ISSN 0168-1656, pages 277 - 290, XP025475898
OPPOSITION- Christie, A. , Butler, M., "Glutamine-based dipeptides are utilized in mammalian cell culture by extracellular hydrolysis catalyzed by a specific peptidase", Journal of Biotechnology, Amsterdam NL , (19941115), vol. 37, no. 3, doi:10.1016/0168-1656(94)90134-1, ISSN 0168-1656, pages 277 - 290, XP025475898
OPPOSITION- Peter Furst, Et Al., "Amino-Acid Substrates in New Bottles: Implications for Clinical Nut ion in the 21st Century", Nutrition, (20000101), vol. 16, no. 7-8, doi:10.1016/S0899-9007(00)00321-X, pages 603 - 606, XP055410600
OPPOSITION- P Fürst , K S Kuhn, "Amino-Acid Substrates in New Bottles: Implications for Clinical Nut ion in the 21st Century", Nutrition, (20000101), vol. 16, no. 7-8, doi:10.1016/S0899-9007(00)00321-X, pages 603 - 606, XP055410600
OPPOSITION- Peter Furs, "Old and New Substrates in Clinical Nutrition ", American Society for Nutritional Sciences, (19980101), vol. 128, doi:10.1093/jn/128.5.789, pages 789 - 796, XP055410585
OPPOSITION- Peter Furst, Et Al., "Old and New Substrates in Clinical Nutrition ", American Society for Nutritional Sciences, (19980101), vol. 128, doi:10.1093/jn/128.5.789, pages 789 - 796, XP055410585
OPPOSITION- Peter Furst, "Old and New Substrates in Clinical Nutrition ", American Society for Nutritional Sciences, (19980101), vol. 128, doi:10.1093/jn/128.5.789, pages 789 - 796, XP055410585
OPPOSITION- KAZUHIKO TABATA, SHIN-ICHI HASHIMOTO, "Fermentative Production of L-Alanyl-L-Glutamine by a Metabolically Engineered Escherichia coli Strain Expressing L-Amino Acid .alpha.-Ligase", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, American Society for Microbiology, US, US , (20071001), vol. 73, no. 20, doi:10.1128/AEM.01249-07, ISSN 0099-2240, pages 6378 - 6385, XP007912741
OPPOSITION- W Druml , H Lochs, E Roth, W Hübl, P Balcke, K Lenz, "Utilization of tyrosine dipeptides and acetyltyrosine in normal and uremic humans", Am J. Physiol., (19910101), vol. 260, no. 2 Pt 1, doi:10.1152/ajpendo.1991.260.2.E280, pages E280 - E285, XP055410622
OPPOSITION- Wilfred Druml, Et Al., "Utilization of tyrosine dipeptides and acetyltyrosine in normal and uremic humans", Am J. Physiol., (19910101), vol. 260, no. 2, doi:10.1152/ajpendo.1991.260.2.E280, pages e280 - e285, XP055410622
SEARCH- YASUFUMI IMAMOTO ET AL, Advantage of Alagln as and Additive to Cell Culture Medium, ANIMAL CELL TECHNOLOGY: BASIC & APPLIED ASPECTS,, PAGE(S) 65 - 71, (20100101), ISBN 978-90-481-3892-0, XP001526136 [A] 1-7 * the whole document *-
SEARCH- DRINGEN R ET AL, "Use of dipeptides for the synthesis of glutathione by astroglia-rich primary cultures.", JOURNAL OF NEUROCHEMISTRY AUG 1997, (199708), vol. 69, no. 2, ISSN 0022-3042, pages 868 - 874, XP055063791 [A] 1-15 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents